Precision Business Insights
Portfolio

 

Gastrointestinal Therapeutics Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Gastrointestinal Therapeutics Market: By Drug (Antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents and Others), Mode of Administration (Oral, Intravenous and Others), Applications (Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer Disease),  Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others, and Geography

 

Global Gastrointestinal Therapeutics Market Report Description:

Global gastrointestinal therapeutics market report gives comprehensive outlook on gastrointestinal therapeutics technology across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global gastrointestinal therapeutics market gives historical, current, and future market sizes (US$ Mn) on the basis of drug, product, application, route of administration, distribution channel and region. This report studies global gastrointestinal therapeutics market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global gastrointestinal therapeutics market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global gastrointestinal therapeutics market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global gastrointestinal therapeutics market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global gastrointestinal therapeutics products.

 

Global Gastrointestinal Therapeutics Market:

The global gastrointestinal therapeutics market estimated to be valued US$ XX Mn in 2018 and elegant to grow at significant CAGR over 2019-2025 due to increase in the prevalence of gastrointestinal diseases majorly due to the change in life style, increased stress, and the culture of late night parties and dinners. Additionally, the unhealthy dietary habits, increasing healthcare expenditure, growth in the geriatric population, increase in the surgical treatments for GI diseases, rising cases of hospitalization due to GI diseases, rise in R&D activities and product approvals for the treatment of various GI diseases are driving the growth of the global gastrointestinal therapeutics market over the forecast timeframe.

 

Increase in the Prevalence of Gastrointestinal Diseases

Increase in the prevalence of gastrointestinal diseases is a key factor drive the global gastrointestinal therapeutics market. According to a report by WHO, colon cancer caused nearly 694,000 deaths in 2014. According to center for disease control and prevention 15.3 Mn adults are diagnosed with ulcers which is approximately 6.2% and 11% of the population suffer from a chronic digestive diseases, with a prevalence rate as high as 35% for those 65 years and over in United States. Moreover, growing healthcare awareness and increasing bacterial diseases that affect the GI tract are anticipated to propel the global gastrointestinal therapeutics market over the forecast years.

 

North America Accounts for Larger Market Revenue Share in Global Gastrointestinal Therapeutics Market

North America accounted for larger revenue share in global gastrointestinal therapeutics market with significant CAGR and expected to dominate further. High prevalence rate of ulcers, high incidence of chronic GI diseases, presence of major suppliers of gastrointestinal therapeutics in the region, advanced healthcare system and product approvals are anticipated to drive the market. Asia pacific gastrointestinal therapeutics market projected to grow at significant rate owing to increase in research and development, increasing patient pool due to change in life style, presence of major generic players in the region, and increase in healthcare expenditure are expected to enhance the market.

 

Competition Assessment

Key player’s profiles in the global gastrointestinal therapeutics market include:

  • Abbott Laboratories (US)
  • Allergan (Ireland)
  • AstraZeneca plc (UK)
  • GlaxoSmithKline Plc (UK)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Pfizer Inc. (US)
  • Bayer AG (Germany)
  • Bausch Health (Canada)
  • Merck & Co., Inc. (US)
  • AbbVie Inc. (US)

Key Findings of the Report:

 

  • Global gastrointestinal therapeutics market expanding at significant CAGR over 2019 to 2025 owing to increase in the prevalence of cancer, diabetes, and other infectious diseases.
  • Based on route of administration, oral route accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer technologies and collaboration strategies to retain market position in global gastrointestinal therapeutics market.

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

 

By Drug Class

  • Antacids
  • laxatives
  • Antidiarrheal agents
  • Antiemetics
  • Antiulcer agents
  • Others

By Product Type

  • Prescription based therapeutics
  • OTC therapeutics

By Route of administration

  • Oral
  • Intravenous
  • Others

 By Application

  • Ulcerative Colitis
  • Crohn’s Disease
  • GERD
  • Irritable Bowel Syndrome
  • Peptic Ulcer Disease (PUD)
  • Others

By Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

 

Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA
  1. Executive Summary
  2. Global Gastrointestinal Therapeutics Market Introduction
    • Global Gastrointestinal Therapeutics Market – Taxonomy
    • Global Gastrointestinal Therapeutics Market –Definitions
      • By Drug Type
      • By Product
      • By Route of Administration
      • By Application
      • By Distribution Channel
      • By Region
  1. Global Gastrointestinal Therapeutics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Gastrointestinal Therapeutics Market Dynamic Factors – Impact Analysis
    • Global Gastrointestinal Therapeutics Market – Competition Landscape
  2. Global Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Gastrointestinal Therapeutics Market, By Drug Type, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Antacids
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laxatives
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antidiarrheal agents
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antiemetics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antiulcer agents
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Product Type, 2014 – 2018 and Forecast, 2019 – 2025
    • Prescription based therapeutics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • OTC therapeutics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Product, Route of Administration, 2014 – 2018 and Forecast, 2019 – 2025
    • Oral
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Intravenous
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market, By Application, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Ulcerative Colitis
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Crohn’s Disease
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • GERD
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Irritable Bowel Syndrome
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptic Ulcer Disease (PUD)
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Distribution Channel, 2014 – 2018 and Forecast, 2019 – 2025
    • Hospital Pharmacies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Region, 2019 – 2025
  2. North America Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • North America Gastrointestinal Therapeutics Market Dynamics – Trends
  3. Europe Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • Europe Gastrointestinal Therapeutics Market Dynamics – Trends
  4. Asia-Pacific Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • Asia-Pacific Gastrointestinal Therapeutics Market Dynamics – Trends
  5. Latin America Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • Latin America Gastrointestinal Therapeutics Market Dynamics – Trends
  6. Middle East and Africa Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • MEA Gastrointestinal Therapeutics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Abbott Laboratories (US)
      • Allergan (Ireland)
      • AstraZeneca plc (UK)
      • GlaxoSmithKline Plc (uk)
      • Takeda Pharmaceutical Company Limited (Japan)
      • Pfizer Inc (US)
      • Bayer AG (Germany)
      • Bausch Health (Canada)
      • Merck & Co., Inc. (US)
      • AbbVie Inc. (US)
  1. Research Methodology
  2. Key Assumptions and Acronyms
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials